As clinical trials become more complex, simulation-guided design approaches are crucial. For this edition of the..
Read more
Learn how simulation-based clinical development tools can enable sponsors to mitigate risk, make informed decisions,..
Read more
Cytel’s Chief Medical Officer, Albert Kim, and Chief Scientific Officer, Yannis Jemiai discuss and demonstrate a new..
Read more
Anna Forsythe, Cytel's Vice President of Value and Access discusses how Cytel is reshaping the relationship between..
Read more
Yannis Jemiai, Cytel's Chief Science Officer reveals how trial sponsors can leverage Solara to quickly explore millions..
Read more
Learn a quantitative approach to optimize your trial selection using a trusted economic framework.
Read more
De-Risking the Unknown: Optimizing Statistical Design for Clinical Strategy
Watch now
How to optimize across all of the performance characteristics of a clinical trial.
Read more
Learn how powerful new simulation and forecasting methods are changing the strategic landscape of clinical trial..
Read more
How broadly should you explore, refine and update designs during clinical trial selection?
Read more
Evidence-driven trial design selection for the 21st century clinical trial.
Read more